Frontlight ResearchEarly access
Trial site
BRCR Medical Center
- 6running trials
- 1closed trial
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Colorectal cancer3 trials
- Pancreatic cancer2 trials
- Gastric and oesophageal cancer1 trial
- Kidney cancer1 trial
- Melanoma1 trial
- Myelodysplastic syndromes1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 12 trials
- Phase 22 trials
- Phase 32 trials
- Phase 2/31 trial
- Status
- Active, not recruiting4 trials
- Recruiting2 trials
- Terminated1 trial
- Lead sponsor
- HUYABIO International, LLC.2 trials
- Geron Corporation1 trial
- Innovent Biologics (Suzhou) Co. Ltd.1 trial
- NeoImmuneTech1 trial
- Protagonist Therapeutics, Inc.1 trial
- and 1 more
Running trials
Recruiting
Recruiting
A Study of IBI363 in Subjects with Advanced Solid Malignancies
Active, not recruiting
A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Kidney cancer1 recruiting
- Lung cancer1 recruiting
- Melanoma1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 13 Nov 2026